- Home
- CCM vs OCEA Comparison
CCM vs OCEA Comparison
Compare CCM & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- OCEA
- Stock Information
- Founded
- CCM 1997
- OCEA 2019
- Country
- CCM China
- OCEA United States
- Employees
- CCM N/A
- OCEA N/A
- Industry
- CCM Medical/Nursing Services
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- OCEA Health Care
- Exchange
- CCM Nasdaq
- OCEA Nasdaq
- Market Cap
- CCM 20.4M
- OCEA 20.5M
- IPO Year
- CCM 2009
- OCEA N/A
- Fundamental
- Price
- CCM $4.70
- OCEA $0.54
- Analyst Decision
- CCM
- OCEA
- Analyst Count
- CCM 0
- OCEA 0
- Target Price
- CCM N/A
- OCEA N/A
- AVG Volume (30 Days)
- CCM 15.7K
- OCEA 617.7K
- Earning Date
- CCM 09-27-2024
- OCEA 01-13-2025
- Dividend Yield
- CCM N/A
- OCEA N/A
- EPS Growth
- CCM N/A
- OCEA N/A
- EPS
- CCM N/A
- OCEA N/A
- Revenue
- CCM $64,910,622.00
- OCEA N/A
- Revenue This Year
- CCM N/A
- OCEA N/A
- Revenue Next Year
- CCM N/A
- OCEA N/A
- P/E Ratio
- CCM N/A
- OCEA N/A
- Revenue Growth
- CCM N/A
- OCEA N/A
- 52 Week Low
- CCM $3.80
- OCEA $0.46
- 52 Week High
- CCM $26.70
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- CCM 47.65
- OCEA 40.01
- Support Level
- CCM $4.42
- OCEA $0.53
- Resistance Level
- CCM $5.09
- OCEA $0.70
- Average True Range (ATR)
- CCM 1.07
- OCEA 0.08
- MACD
- CCM -0.02
- OCEA -0.00
- Stochastic Oscillator
- CCM 11.67
- OCEA 4.31
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.